Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Breast Neoplasms 7Lung Neoplasms 5Glioblastoma 5Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Stomach Neoplasms 3Rectal Neoplasms 3Liver Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Prostatic Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Gliosarcoma 2Glioma 2Colorectal Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Ductal, Breast 2Vomiting 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Tumor Response Rate 1Thrombosis 1Solitary Fibrous Tumor, Pleural 1Skin Abnormalities 1Radiation Therapy 1Radiation Injuries 1Pain 1

Interventions

Taxes 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Paclitaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Endometrial Serous Adenocarcinoma × Radiotherapy, Conformal × Clear all
NCT02112552 2023-08-29

Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer

Albert Einstein College of Medicine

Phase 2 Terminated
4 enrolled 6 charts
Gynecologic

Endometrial Serous Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡